The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

J Steffel, P Verhamme, TS Potpara… - European heart …, 2018 - academic.oup.com
The current manuscript is the second update of the original Practical Guide, published in
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive …

J Steffel, P Verhamme, TS Potpara, P Albaladejo… - EP …, 2018 - academic.oup.com
The current manuscript is the Executive Summary of the second update to the original
Practical Guide, published in 2013. Non-vitamin K antagonist oral anticoagulants (NOACs) …

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive …

J Steffel, P Verhamme, TS Potpara, P Albaladejo… - Kardiologia …, 2018 - diva-portal.org
Poniższy tekst jest streszczeniem drugiej aktualizacji oryginalnego praktycznego
przewodnika opublikowanego w 2013 roku. Leki przeciwkrzepliwe niebędące …

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

J Steffel, P Verhamme, TS Potpara… - European Heart …, 2018 - search.ebscohost.com
The current manuscript is the second update of the original Practical Guide, published in
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …

[PDF][PDF] The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation …

J Steffel, P Verhamme, TS Potpara, P Albaladejo… - researchgate.net
The proper use of non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) for stroke
prevention in patients with atrial fibrillation (AF) requires a diligent approach in various …

[PDF][PDF] The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

J Steffel, P Verhamme, TS Potpara, P Albaladejo… - education.gnicpm.ru
SEE Systemic embolic event, SmPC Summary of product characteristics, STEMI ST-
elevation myocardial infarction, TIA Transient ischaemic attack, TT Thrombin time, TTR Time …

[PDF][PDF] The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

J Steffel, P Verhamme, TS Potpara… - European Heart …, 2018 - scholar.archive.org
SEE Systemic embolic event, SmPC Summary of product characteristics, STEMI ST-
elevation myocardial infarction, TIA Transient ischaemic attack, TT Thrombin time, TTR Time …

[PDF][PDF] The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

J Steffel, P Verhamme, TS Potpara, P Albaladejo… - escardio.org
1. Eligibility for NOACs 2. Practical start-up and follow-up scheme for patients on NOACs 3.
Ensuring adherence to prescribed oral anticoagulant intake 4. Switching between …

[PDF][PDF] The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

J Steffel, P Verhamme, TS Potpara, P Albaladejo… - tromboos.ee
1. Eligibility for NOACs 2. Practical start-up and follow-up scheme for patients on NOACs 3.
Ensuring adherence to prescribed oral anticoagulant intake 4. Switching between …

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive …

J Steffel, P Verhamme, TS Potpara… - Polish Heart …, 2018 - journals.viamedica.pl
Poniższy tekst jest streszczeniem drugiej aktualizacji oryginalnego praktycznego
przewodnika opublikowanego w 2013 roku. Leki przeciwkrzepliwe niebędące …